David Booth
David Booth
Verified email at sydney.edu.au
Cited by
Cited by
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
S Sawcer, G Hellenthal, M Pirinen, CCA Spencer, NA Patsopoulos, ...
Nature 476 (7359), 214, 2011
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
V Suppiah, M Moldovan, G Ahlenstiel, T Berg, M Weltman, ML Abate, ...
Nature genetics 41 (10), 1100, 2009
Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
DR Booth, M Sunde, V Bellotti, CV Robinson, WL Hutchinson, PE Fraser, ...
Nature 385 (6619), 787-793, 1997
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
Nature Genetics, 2013
Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis
HJ Lachmann, DR Booth, SE Booth, A Bybee, JA Gilbertson, JD Gillmore, ...
New England Journal of Medicine 346 (23), 1786-1791, 2002
Human lysozyme gene mutations cause hereditary systemic amyloidosis
MB Pepys, PN Hawkins, DR Booth, DM Vigushin, GA Tennent, AK Soutar, ...
Nature 362 (6420), 553-557, 1993
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
Australia and New Zealand Multiple Sclerosis Genetics Consortium
Nature genetics 41 (7), 824, 2009
Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA …
E Aganna, F Martinon, PN Hawkins, JB Ross, DC Swan, DR Booth, ...
Arthritis & Rheumatism 46 (9), 2445-2452, 2002
Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations
HJ Lachmann, B Şengül, TU Yavuzşen, DR Booth, SE Booth, A Bybee, ...
Rheumatology 45 (6), 746-750, 2006
Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci
NA Patsopoulos, ...
Annals of neurology 70 (6), 897-912, 2011
A high-density screen for linkage in multiple sclerosis
International Multiple Sclerosis Genetics Consortium
The American Journal of Human Genetics 77 (3), 454-467, 2005
Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever
I Touitou, T Sarkisian, M Medlej‐Hashim, M Tunca, A Livneh, D Cattan, ...
Arthritis & Rheumatism 56 (5), 1706-1712, 2007
MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood
MB Cox, MJ Cairns, KS Gandhi, AP Carroll, S Moscovis, GJ Stewart, ...
PloS one 5 (8), e12132, 2010
Class II HLA interactions modulate genetic risk for multiple sclerosis
L Moutsianas, L Jostins, AH Beecham, AT Dilthey, DK Xifara, M Ban, ...
Nature genetics 47 (10), 1107, 2015
Potential role for Interleukin‐28B genotype in treatment decision‐making in recent hepatitis C virus infection
J Grebely, K Petoumenos, M Hellard, GV Matthews, V Suppiah, ...
Hepatology 52 (4), 1216-1224, 2010
Amyloid P component. A critical review
MB Pepys, DR Booth, WL Hutchinson, JR Gallimore, IM Collins, ...
Amyloid 4 (4), 274-295, 1997
The genetic basis of autosomal dominant familial Mediterranean fever
DR Booth, JD Gillmore, HJ Lachmann, SE Booth, A Bybee, M Soytürk, ...
Qjm 93 (4), 217-221, 2000
The role of the CD58 locus in multiple sclerosis
PL De Jager, C Baecher-Allan, LM Maier, AT Arthur, L Ottoboni, ...
Proceedings of the National Academy of Sciences 106 (13), 5264-5269, 2009
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
International Multiple Sclerosis Genetics Consortium*†, ANZgene, ...
Science 365 (6460), eaav7188, 2019
Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis
S Ramanathan, SW Reddel, A Henderson, JDE Parratt, M Barnett, ...
Neurology-Neuroimmunology Neuroinflammation 1 (4), 2014
The system can't perform the operation now. Try again later.
Articles 1–20